Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Korean J Ophthalmol ; 34(4): 311-315, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32783424

RESUMO

PURPOSE: We sought to investigate the temporal changes of eyelid height after phenylephrine instillation in Korean patients with and without ptosis to determine the time points of the first and maximum reactions. METHODS: The phenylephrine test was performed on 16 eyes of 12 ptotic patients (group I) and 24 eyes of 12 normal control subjects (group II) in our hospital between September 2017 and March 2018. One drop of 2.5% phenylephrine was instilled and the marginal reflex distance 1 (MRD1) was measured at 15 seconds before instillation and the following time points after instillation: at 15-second intervals for the initial 5 minutes and at 5-minute intervals until a total of 20 minutes was reached (i.e., at 10, 15, and 20 minutes). RESULTS: In group I patients, the first reaction appeared at 5 minutes (p = 0.034), while the maximum eyelid height after the first reaction was reached at 15 minutes (p = 0.025) and was maintained until 20 minutes. In group II subjects, the first reaction appeared at 5 minutes (p = 0.034), while the maximum eyelid height was reached at 10 minutes (p = 0.015) and was maintained until 20 minutes. There was no significant difference in the response of eyelid height based on time (p = 0.122) between the two groups. CONCLUSIONS: Our analysis of phenylephrine test results in Korean ptotic patients revealed a significant increase occurred in the eyelid height after 5 minutes; meanwhile, the maximum eyelid height was reached at 15 minutes and was maintained until 20 minutes after instillation.


Assuntos
Blefaroptose/tratamento farmacológico , Fenilefrina/administração & dosagem , Agonistas de Receptores Adrenérgicos alfa 1/administração & dosagem , Blefaroptose/diagnóstico , Blefaroptose/epidemiologia , Relação Dose-Resposta a Droga , Pálpebras/diagnóstico por imagem , Pálpebras/efeitos dos fármacos , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Soluções Oftálmicas , República da Coreia/epidemiologia , Estudos Retrospectivos , Fatores de Tempo
2.
J AAPOS ; 18(2): 193-5, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24582467

RESUMO

Herpes zoster ophthalmicus is rare in healthy children. It is occasionally associated with extraocular muscle palsies and rarely with isolated trochlear nerve palsy. We report a case of unilateral isolated trochlear nerve palsy associated with herpes zoster ophthalmicus in an immunocompetent 13-year-old girl who presented with diplopia and blurred vision in her right eye. The right cornea had multiple subepithelial opacities. Ocular motility returned to normal and diplopia and corneal opacification resolved with steroid therapy. To our knowledge, this is the first such case involving the troclear nerve in a child.


Assuntos
Diplopia/complicações , Herpes Zoster Oftálmico/complicações , Doenças do Nervo Troclear/complicações , Aciclovir/uso terapêutico , Administração Oral , Adolescente , Antivirais/uso terapêutico , Opacidade da Córnea/complicações , Opacidade da Córnea/diagnóstico , Opacidade da Córnea/tratamento farmacológico , Diplopia/diagnóstico , Diplopia/tratamento farmacológico , Feminino , Glucocorticoides/administração & dosagem , Glucocorticoides/uso terapêutico , Herpes Zoster Oftálmico/diagnóstico , Herpes Zoster Oftálmico/tratamento farmacológico , Humanos , Infusões Intravenosas , Metilprednisolona/administração & dosagem , Soluções Oftálmicas , Prednisolona/uso terapêutico , Doenças do Nervo Troclear/diagnóstico , Doenças do Nervo Troclear/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA